Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).

Møller-Bisgaard S, Ejbjerg BJ, Eshed I, Hørslev-Petersen K, Hetland ML, Jurik AG, Thomsen H, Torfing T, Stengaard-Pedersen K, Junker P, Krogh NS, Lottenburger T, Ellingsen T, Andersen LS, Skjødt H, Svendsen AJ, Tarp U, Hansen IT, Pødenphant J, Pedersen JK, Lindegaard H, Hanson LG, Vestergaard A, Glinatsi D, Østergaard M

Open source

DOI
10.1080/03009742.2016.1209550
Published
2017 Sep
Container
Scandinavian journal of rheumatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/03009742.2016.1209550,
  title = {Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).},
  author = {Møller-Bisgaard S and Ejbjerg BJ and Eshed I and Hørslev-Petersen K and Hetland ML and Jurik AG and Thomsen H and Torfing T and Stengaard-Pedersen K and Junker P and Krogh NS and Lottenburger T and Ellingsen T and Andersen LS and Skjødt H and Svendsen AJ and Tarp U and Hansen IT and Pødenphant J and Pedersen JK and Lindegaard H and Hanson LG and Vestergaard A and Glinatsi D and Østergaard M},
  year = {2017},
  journal = {Scandinavian journal of rheumatology},
  doi = {10.1080/03009742.2016.1209550},
  url = {https://doi.org/10.1080/03009742.2016.1209550}
}

RIS

TY  - JOUR
TI  - Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).
AU  - Møller-Bisgaard S
AU  - Ejbjerg BJ
AU  - Eshed I
AU  - Hørslev-Petersen K
AU  - Hetland ML
AU  - Jurik AG
AU  - Thomsen H
AU  - Torfing T
AU  - Stengaard-Pedersen K
AU  - Junker P
AU  - Krogh NS
AU  - Lottenburger T
AU  - Ellingsen T
AU  - Andersen LS
AU  - Skjødt H
AU  - Svendsen AJ
AU  - Tarp U
AU  - Hansen IT
AU  - Pødenphant J
AU  - Pedersen JK
AU  - Lindegaard H
AU  - Hanson LG
AU  - Vestergaard A
AU  - Glinatsi D
AU  - Østergaard M
PY  - 2017
JO  - Scandinavian journal of rheumatology
DO  - 10.1080/03009742.2016.1209550
UR  - https://doi.org/10.1080/03009742.2016.1209550
ER  - 

APA

S, M., BJ, E., I, E., K, H., ML, H., AG, J., H, T., T, T., K, S., P, J., NS, K., T, L., T, E., LS, A., H, S., AJ, S., U, T., IT, H., J, P., JK, P., H, L., LG, H., A, V., D, G., & M, Ø. (2017). Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA).. Scandinavian journal of rheumatology. https://doi.org/10.1080/03009742.2016.1209550

Source records